24 October 2024
24 October 2024
Abrysvo is now approved to prevent lower respiratory tract disease caused by RSV in high-risk adults aged over 18 years.
There are already two FDA-approved gene therapies for haemophilia B courtesy of Pfizer and CSL Behring.
The UK’s National Institute of Health and Care Excellence (NICE) said the drug provided only a small benefit to patients.
Darzalex will now be available to patients with newly diagnosed multiple myeloma eligible for autologous stem cell transplant.
The partnership will leverage the university's research and TreeFrog's tech to pioneer advancements.
Lumos will continue as DPV’s indirect wholly-owned subsidiary, operating as a standalone business.
Large language models (LLMs) such as ChatGPT are frequently hailed as revolutionary tools for any workplace. However, in the pharma industry, smaller-scale supervised machine learning models could provide more effective and reliable solutions.
The combined company will be named Opus Genetics.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
